Get started
ELEVANCE HEALTH DL-,01ELEVANCE HEALTH DL-,01ELEVANCE HEALTH DL-,01

ELEVANCE HEALTH DL-,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

A58 chart


Full chart

Key facts today


Elevance Health, Inc. is facing a class action lawsuit alleging false statements about its operations and unaccounted costs related to sicker Medicaid patients from April to October 2024.
A lawsuit has been filed against Elevance Health, Inc. and its executives for alleged federal securities law violations. Investors can seek lead plaintiff status until July 11, 2025.
Analyze the impactAnalyze the impact

A58 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪75.62 B‬ EUR
Dividend yield (indicated)
1.81%
Price to earnings Ratio (TTM)
14.9
Basic EPS (TTM)
23.8 EUR
Net income (FY)
‪5.78 B‬ EUR
Revenue (FY)
‪170.79 B‬ EUR
Shares float
‪225.55 M‬
Beta (1Y)
0.21

Employees


Employees (FY)
‪104.2 K‬
Change (1Y)
−700 −0.67%
Revenue / Employee (1Y)
‪1.64 M‬ EUR
Net income / Employee (1Y)
‪55.44 K‬ EUR

About Elevance Health, Inc.


Sector
Health Services
Industry
Managed Health Care
CEO
Gail Koziara Boudreaux
Website
elevancehealth.com
Headquarters
Indianapolis
Founded
1944
FIGI
BBG000BHX743
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Financials


Performance
Revenue to profit conversion
Insurance reserves, claims and premiums
Earnings
Next:—

A58 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

A58 highest yielding bonds


ANTM4983288
Elevance Health, Inc. 3.125% 15-MAY-2050
Yield to maturity
7.37%
Maturity date
May 15, 2050
US36752AS2
ELEVANCE HE. 21/51
Yield to maturity
7.20%
Maturity date
Mar 15, 2051
ANTM4880736
Elevance Health, Inc. 3.7% 15-SEP-2049
Yield to maturity
7.16%
Maturity date
Sep 15, 2049
ANTM4153492
Elevance Health, Inc. 4.85% 15-AUG-2054
Yield to maturity
6.94%
Maturity date
Aug 15, 2054
AE1J
ELEVANCE HE. 17/47
Yield to maturity
6.73%
Maturity date
Dec 1, 2047
ANTM4606236
Anthem, Inc. /Old/ 4.55% 01-MAR-2048
Yield to maturity
6.72%
Maturity date
Mar 1, 2048
ANTM5405192
Elevance Health, Inc. 4.55% 15-MAY-2052
Yield to maturity
6.69%
Maturity date
May 15, 2052
ANTM3851462
Elevance Health, Inc. 4.625% 15-MAY-2042
Yield to maturity
6.53%
Maturity date
May 15, 2042
ANTM4153493
Elevance Health, Inc. 4.65% 15-AUG-2044
Yield to maturity
6.53%
Maturity date
Aug 15, 2044
ELVH5534305
Elevance Health, Inc. 5.125% 15-FEB-2053
Yield to maturity
6.51%
Maturity date
Feb 15, 2053
ANTM3899002
Elevance Health, Inc. 4.65% 15-JAN-2043
Yield to maturity
6.48%
Maturity date
Jan 15, 2043

See all A58 bonds 


Check out other big names from the same industry as A58.

Frequently Asked Questions


The current price of A58 is 338.0 EUR — it has increased by 0.09% in the past 24 hours. Watch ELEVANCE HEALTH DL-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ELEVANCE HEALTH DL-,01 stocks are traded under the ticker A58.
A58 stock has fallen by −2.99% compared to the previous week, the month change is a −6.76% fall, over the last year ELEVANCE HEALTH DL-,01 has showed a −29.04% decrease.
We've gathered analysts' opinions on ELEVANCE HEALTH DL-,01 future price: according to them, A58 price has a max estimate of 518.64 EUR and a min estimate of 379.45 EUR. Watch A58 chart and read a more detailed ELEVANCE HEALTH DL-,01 stock forecast: see what analysts think of ELEVANCE HEALTH DL-,01 and suggest that you do with its stocks.
A58 reached its all-time high on Nov 2, 2022 with the price of 551.0 EUR, and its all-time low was 96.4 EUR and was reached on Dec 17, 2014. View more price dynamics on A58 chart.
See other stocks reaching their highest and lowest prices.
A58 stock is 1.41% volatile and has beta coefficient of 0.21. Track ELEVANCE HEALTH DL-,01 stock price on the chart and check out the list of the most volatile stocks — is ELEVANCE HEALTH DL-,01 there?
Today ELEVANCE HEALTH DL-,01 has the market capitalization of ‪75.62 B‬, it has decreased by −1.82% over the last week.
Yes, you can track ELEVANCE HEALTH DL-,01 financials in yearly and quarterly reports right on TradingView.
ELEVANCE HEALTH DL-,01 is going to release the next earnings report on Jul 16, 2025. Keep track of upcoming events with our Earnings Calendar.
A58 earnings for the last quarter are 11.06 EUR per share, whereas the estimation was 10.55 EUR resulting in a 4.89% surprise. The estimated earnings for the next quarter are 8.19 EUR per share. See more details about ELEVANCE HEALTH DL-,01 earnings.
ELEVANCE HEALTH DL-,01 revenue for the last quarter amounts to ‪45.08 B‬ EUR, despite the estimated figure of ‪42.80 B‬ EUR. In the next quarter, revenue is expected to reach ‪42.63 B‬ EUR.
A58 net income for the last quarter is ‪2.02 B‬ EUR, while the quarter before that showed ‪403.78 M‬ EUR of net income which accounts for 399.74% change. Track more ELEVANCE HEALTH DL-,01 financial stats to get the full picture.
Yes, A58 dividends are paid quarterly. The last dividend per share was 1.58 EUR. As of today, Dividend Yield (TTM)% is 1.75%. Tracking ELEVANCE HEALTH DL-,01 dividends might help you take more informed decisions.
ELEVANCE HEALTH DL-,01 dividend yield was 1.77% in 2024, and payout ratio reached 25.39%. The year before the numbers were 1.26% and 23.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has ‪104.2 K‬ employees. See our rating of the largest employees — is ELEVANCE HEALTH DL-,01 on this list?
Like other stocks, A58 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELEVANCE HEALTH DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELEVANCE HEALTH DL-,01 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELEVANCE HEALTH DL-,01 stock shows the sell signal. See more of ELEVANCE HEALTH DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.